PRAX 8-K: SEC filing

Praxis Precision Medicines

Filed with the SEC on Nov 9, 2026 · accession 0001689548-26-000086

PRAX filed a 8-K (current report) with the SEC on Nov 9, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Praxis Precision Medicines announced its financial results for the quarter ended September 30, 2026, via a press release furnished as Exhibit 99.1 to its Form 8-K.

For details, click here →How to read a 8-K →

Key details

RegistrantPraxis Precision Medicines, Inc.

Chief executive officerMarcio Souza

✦ Ask GOAX AI about this filing — what it means for PRAX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PRAX?

Click here

Frequently asked questions

What did PRAX file with the SEC on Nov 9, 2026?

PRAX filed a 8-K (SEC filing). Praxis Precision Medicines announced its financial results for the quarter ended September 30, 2026, via a press release furnished as Exhibit 99.1 to its Form 8-K.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other PRAX SEC filings

Get alerts when PRAX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

PRAX overview PRAX analysis PRAX news Latest SEC filings